AIM
OPRX icon

Alambic Investment Management’s OptimizeRx OPRX Stock Holding History

Alambic Investment Management’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-10,330
Closed -$150K – 328
2019
Q3 		$150K Buy
+10,330
New +$160K 0.11% 240
2019
Q2 		– Sell
-12,216
Closed -$155K – 363
2019
Q1 		$155K Sell
12,216
-14,150
-54% -$184K 0.06% 303
2018
Q4 		$289K Buy
+26,366
New +$390K 0.12% 222

Other funds holding OPRX

AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $549M AUM 179.59% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
PAWC
P.A.W. Capital Greenwich, Connecticut $131M AUM 35.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Alambic Investment Management's OPRX Position: Q4 2019 in Review

Alambic Investment Management sold out of OptimizeRx (OPRX) in Q4 2019, closing a stake of 10,330 shares — an estimated $150K sold.

Alambic Investment Management first reported a position in OPRX in Q4 2018 and held it in 3 quarters. The position peaked at $289K in Q4 2018. 56 funds tracked by Wall St. Rank hold OPRX as of Q4 2019.

  • Alambic Investment Management reported no remaining OptimizeRx position as of Q4 2019 after selling out during the quarter.
  • Alambic Investment Management sold 10,330 OptimizeRx shares in Q4 2019, an estimated $150K.
  • Alambic Investment Management first reported a position in OptimizeRx in Q4 2018 and held it in 3 quarters.
  • Alambic Investment Management's OptimizeRx position peaked at $289K in Q4 2018.
  • 56 funds tracked by Wall St. Rank held OptimizeRx as of Q4 2019.

Based on Alambic Investment Management's 13F filing for Q4 2019, filed 12 Feb 2020.